Skip to main content

Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance.

Citation
He, F., et al. “Mitophagy-Mediated Adipose Inflammation Contributes To Type 2 Diabetes With Hepatic Insulin Resistance.”. The Journal Of Experimental Medicine.
Center Yale University
Author Feng He, Yanrui Huang, Zhi Song, Huanjiao Jenny Zhou, Haifeng Zhang, Rachel J Perry, Gerald I Shulman, Wang Min
Abstract

White adipose tissues (WAT) play crucial roles in maintaining whole-body energy homeostasis, and their dysfunction can contribute to hepatic insulin resistance and type 2 diabetes mellitus (T2DM). However, the mechanisms underlying these alterations remain unknown. By analyzing the transcriptome landscape in human adipocytes based on available RNA-seq datasets from lean, obese, and T2DM patients, we reveal elevated mitochondrial reactive oxygen species (ROS) pathway and NF-κB signaling with altered fatty acid metabolism in T2DM adipocytes. Mice with adipose-specific deletion of mitochondrial redox Trx2 develop hyperglycemia, hepatic insulin resistance, and hepatic steatosis. Trx2-deficient WAT exhibited excessive mitophagy, increased inflammation, and lipolysis. Mechanistically, mitophagy was induced through increasing ROS generation and NF-κB-dependent accumulation of autophagy receptor p62/SQSTM1, which recruits damaged mitochondria with polyubiquitin chains. Importantly, administration of ROS scavenger or NF-κB inhibitor ameliorates glucose and lipid metabolic disorders and T2DM progression in mice. Taken together, this study reveals a previously unrecognized mechanism linking mitophagy-mediated adipose inflammation to T2DM with hepatic insulin resistance.

Year of Publication
2021
Journal
The Journal of experimental medicine
Volume
218
Issue
3
Date Published
03/2021
ISSN Number
1540-9538
DOI
10.1084/jem.20201416
Alternate Journal
J Exp Med
PMID
33315085
PMCID
PMC7927432
Download citation